Last reviewed · How we verify

NCT06951802

Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine

Recruiting now Phase 4 Last updated 30 April 2025
What this trial tests

Phase 4 trial testing Ketamine in Endometriosis in 118 participants. Currently enrolling.

Timeline
3 December 2024
Primary endpoint
30 June 2025
31 December 2026

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment118
Start date3 December 2024
Primary completion30 June 2025
Estimated completion31 December 2026
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

18 and older, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

RCT comparing intraoperative administration of low-dose ketamine during laparoscopic endometriosis operation and the postoperative pain outcome

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Opioid-sparing by low-dose ketamine for endometriosis surgery. A single-center, prospective, randomized, trial.
    Vetter C. · · 2026 · PMID 41550074 · DOI 10.1080/17581869.2026.2613800

Verify or expand the search:

Other trials of Ketamine

Trials testing the same drug.

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06951802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing